Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.5371
-0.0328 (-5.76%)
Nov 3, 2025, 3:58 PM EST
Biotricity Market Cap
Biotricity has a market cap or net worth of $14.48 million as of November 3, 2025. Its market cap has increased by 185.79% in one year.
Market Cap
14.48M
Enterprise Value
43.04M
Revenue
14.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.54
Market Cap Chart
Since February 18, 2016, Biotricity's market cap has decreased from 187.13M to 14.48M, a decrease of -92.26%. That is a compound annual growth rate of -23.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 15.36M | 115.81% |
| Dec 31, 2024 | 7.12M | -31.33% |
| Dec 29, 2023 | 10.37M | -61.10% |
| Dec 30, 2022 | 26.65M | -88.14% |
| Dec 31, 2021 | 224.72M | 464.80% |
| Dec 31, 2020 | 39.79M | 13.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 563.78M |
| Northwest Biotherapeutics | 377.06M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 311.89M |
| American Oncology Network | 302.09M |
| CytoDyn | 297.30M |